Dr. Nadia Malik , MD
Internal Medicine • Grapevine, TX
4100 Heritage Ave Ste 102
Grapevine, TX 760515716
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 5, 2007; this date does not establish years in practice.
-
Published CMS data list 653 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 217 service units.
- 99213 — Established patient outpatient office visit: 115 service units.
- 99454 — Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days: 107 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,636 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 292 prescription fills, including refills.
- Levothyroxine Sodium — 185 prescription fills, including refills.
- Montelukast Sodium — 175 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 55 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 65% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: 771. Middle half: 471 to 1,824.
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 162 in 2020 to 653 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4100 Heritage Ave Ste 102
Grapevine, TX 760515716
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1999
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
70 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $53,268 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $39,629 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
7,188 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$436,921 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,370.54 across 71 records.
By nature of payment
- Food and Beverage: $1,370.54 across 71 records.
Reporting-company totals (3 largest of 17)
- Bayer Healthcare Pharmaceuticals Inc.: $211.25 across 10 records.
- Intra-Sana Laboratories: $175.64 across 9 records.
- AstraZeneca Pharmaceuticals LP: $172.20 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
27 years (graduated 1999)
CMS Doctors and Clinicians data list 1999 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Malik has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Malik as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Grapevine and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 65% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: 771. Middle half: 471 to 1,824.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Medicare-allowed amount
A lower Medicare-allowed amount than 65% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: $81,038. Middle half: $42,161 to $159,456.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $61,221. Middle half: $27,420 to $115,826.
Paid by Medicare
A lower Medicare payment amount than 65% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: $63,276. Middle half: $32,939 to $124,985.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $47,501. Middle half: $20,446 to $90,051.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine in Grapevine, TX (2024, 20 clinicians with data). Median for this group: 1,914. Middle half: 132 to 4,546.
More Part D prescriptions than 60% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 20 clinicians with data). Median for this group: $163,036. Middle half: $11,144 to $417,004.
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
27 active clinicians are listed under Internal Medicine with a practice address in Grapevine, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Grapevine
29.6% of these 27 clinicians have the CMS telehealth indicator.
70.4% of these 27 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 303% from 162 in 2020 to 653 in 2024.
- 2020: 162
- 2021: 291
- 2022: 396
- 2023: 373
- 2024: 653
-
Medicare-allowed amount
Medicare-allowed amount increased 226% from $16,351 in 2020 to $53,268 in 2024.
- 2020: $16,351
- 2021: $22,982
- 2022: $34,654
- 2023: $31,407
- 2024: $53,268
-
Paid by Medicare
Paid by Medicare increased 228% from $12,072 in 2020 to $39,629 in 2024.
- 2020: $12,072
- 2021: $16,974
- 2022: $25,861
- 2023: $22,163
- 2024: $39,629
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 129% from 1,150 in 2020 to 2,636 in 2024.
- 2020: 1,150
- 2021: 1,498
- 2022: 1,800
- 2023: 2,391
- 2024: 2,636
-
30-day fills
30-day fills increased 130% from 3,122 in 2020 to 7,188 in 2024.
- 2020: 3,122
- 2021: 4,128
- 2022: 4,809
- 2023: 6,421
- 2024: 7,188
-
Part D drug cost
Part D drug cost increased 352% from $96,585 in 2020 to $436,921 in 2024.
- 2020: $96,585
- 2021: $109,535
- 2022: $238,248
- 2023: $439,523
- 2024: $436,921
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $981.30 in 2021 to $1,370.54 in 2025.
- 2021: $981.30
- 2022: $1,420.86
- 2023: $1,597.46
- 2024: $1,140.29
- 2025: $1,370.54
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 71 records totaling $1,370.54.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Intra-Sana Laboratories |
Food and Beverage
In-kind items and services
|
RELTONE 200 MG | General | $88.42 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $54.51 |
| Impulse Dynamics (USA) Inc. |
Food and Beverage
Cash or cash equivalent
|
Optimizer | General | $35.92 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $30.24 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $28.25 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $28.25 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $28.20 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $27.79 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $24.98 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $24.68 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $24.55 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $23.82 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $23.56 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $23.26 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $22.96 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $22.65 |
| Intra-Sana Laboratories |
Food and Beverage
In-kind items and services
|
RELTONE 200 MG | General | $22.58 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $22.43 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $22.03 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $21.74 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $21.52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $21.40 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $21.36 |
| IBSA Pharma Inc. |
Food and Beverage
Cash or cash equivalent
|
Tirosint | General | $20.91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $20.79 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
217 | 63 | $521.00 | $126.01 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
115 | 41 | $351.00 | $88.78 |
|
99454
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
|
107 | 20 | $96.96 | $45.77 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
100 | 24 | $98.05 | $47.71 |
|
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
|
39 | 20 | $100.00 | $38.66 |
|
96372
Injection of drug or substance under skin or into muscle
|
30 | 20 | $120.00 | $14.08 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
23 | 20 | $704.00 | $177.80 |
|
J3420
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
|
22 | 14 | $50.00 | $1.21 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 292 | 26,080 | $2,542.24 | 82 |
| Levothyroxine Sodium | Levothyroxine Sodium | 185 | 16,530 | $1,268.60 | 50 |
| Montelukast Sodium | Montelukast Sodium | 175 | 15,550 | $1,432.19 | 61 |
| Metformin Hcl | Metformin Hcl | 164 | 14,500 | $1,151.99 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 135 | 11,790 | $830.64 | 37 |
| Losartan Potassium | Losartan Potassium | 114 | 9,870 | $801.80 | 34 |
| Ezetimibe | Ezetimibe | 111 | 9,800 | $1,638.23 | 34 |
| Atorvastatin Calcium | Atorvastatin Calcium | 91 | 7,750 | $676.48 | 28 |
| Mounjaro | Tirzepatide | 91 | 3,668 | $129,859.42 | 19 |
| Gabapentin | Gabapentin | 84 | 7,370 | $1,764.83 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 82 | 7,130 | $719.88 | 27 |
| Lisinopril | Lisinopril | 67 | 5,960 | $782.24 | 16 |
| Alendronate Sodium | Alendronate Sodium | 60 | 4,536 | $427.02 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 3,910 | $1,412.26 | 29 |
| Omeprazole | Omeprazole | 44 | 3,970 | $767.65 | 16 |
| Azithromycin | Azithromycin | 41 | 205 | $103.16 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 40 | 3,480 | $427.16 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 40 | 3,550 | $348.94 | 12 |
| Metformin Hcl Er | Metformin Hcl | 40 | 3,480 | $159.55 | 11 |
| Liothyronine Sodium | Liothyronine Sodium | 39 | 3,510 | $1,031.64 | 12 |
| Ozempic | Semaglutide | 38 | 1,806 | $59,847.13 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | 3,030 | $152.04 | — |
| Jardiance | Empagliflozin | 32 | 2,280 | $45,927.53 | — |
| Linzess | Linaclotide | 30 | 2,340 | $42,505.90 | — |
| Vascepa | Icosapent Ethyl | 29 | 2,370 | $28,090.72 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20080501000521
TX
2062516099
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4100 HERITAGE AVE STE 102, GRAPEVINE, TX 760515716 (Tel: 6829998446)
Registered at 4100 HERITAGE AVE STE 102, GRAPEVINE, TX 760515716 (Tel: 6829998446)
Internal Medicine (license number reported to NPPES: OH 35088931)
NPI status registered as active in NPPES database
Registered at 14131 MIDWAY RD, SUITE 620, ADDISON, TX 750013623 (Tel: 9722490200)
Registered at 14131 MIDWAY RD, SUITE 620, ADDISON, TX 750013623 (Tel: 9722490200)
Recorded as NADIA MALIK, MD
Internal Medicine (license number reported to NPPES: TX M9478)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Grapevine
- Dr. Rasheed Azam, MD
- Dr. Cameron Fazeli, DO
- Dr. Monalisa Mitra, DO
- Dr. Ashley Fagan, DO
- Dr. John Page, MD
- Dr. Joseph Zadeh, DO
Mailing Address
4100 Heritage Ave Ste 102
Grapevine, TX 760515716
Phone: 6829998446